Although the impact of the peptide has not been tested in a CF model, rescuing BECN1 expression or activity can effectively restore normal autophagy in cells harboring mutation in CFTR, suggesting that this peptide may have some utility in the treatment of CF-associated lung infections.3 The gene discussed is CFTR; the disease is cystic fibrosis.